The treatment of disc herniation-induced sciatica with infliximab: Results of a randomized, controlled, 3-month follow-up study

Spine

Volumn 30, Issue 24, 2005, Pages 2724-2728

  Korhonen, Timo ^a   Karppinen, Jaro ^a,b,c   Paimela, Leena ^c   Malmivaara, Antti ^c,d   Lindgren, Karl August ^c   Järvinen, Simo ^c   Niinimäki, Jaakko ^a   Veeger, Nic ^e   Seitsalo, Seppo ^c   Hurri, Heikki ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cytokine; Disc herniation; Infliximab; Lumbar radicular pain; Randomized controlled trial; Sciatica; TNF

Indexed keywords

INFLIXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EVALUATION; FEMALE; HUMAN; INTERVERTEBRAL DISK HERNIA; INTERVERTEBRAL DISKECTOMY; ISCHIALGIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANK SUM TEST; VISUAL ANALOG SCALE;

EID: 29444448264     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000190815.13764.64     Document Type: Article

References (15)

1. van Akkerveeken PF. Pain patterns and diagnostic blocks. In: Wiesel SW, Weinstein JN, Herkowitz H, et al, eds. The Lumbar Spine. Philadelphia: Saunders, 1996.
2. Mixter WJ, Barr JS. Rupture of the intervertebral disc with involvement of the spinal canal. N Engl J Med 1934;211:210-5.
3. Weber H. Lumbar disc herniation: a controlled, prospective study with ten years of observation. Spine 1983;8:131-40.
4. Marshall LL, Trethewie ER. Chemical irritation of nerve-root in disc prolapse. Lancet 1973;2:320.
5. McCarron RF, Wimpee MW, Hudkins PG, et al. The inflammatory effect of nucleus pulposus: a possible element in the pathogenesis of low-back pain. Spine 1987;12:760-4.
6. Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 1993;18:1425-32.
7. Igarashi T, Kikuchi S, Shubayev V, et al. Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology: molecular, histologic, and behavioral comparisons in rats. Spine 2000;25:2975-80.
8. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 2001;26:863-9.
9. Karppinen J, Korhonen T, Malmivaara A, et al. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine 2003;28:750-3.
10. Agency for Health Care Policy and Research. Acute Low Back Problems in Adults: Clinical Practice Guidelines 14. Rockville, MD: U.S. Department of Health and Human Services, 1994.
11. Genevay S, Stingelin S, Gabay C. Efficacy of etanercept in the treatment of acute and severe sciatica: a pilot study. Ann Rheum Dis 2004;63:1120-3.
12. Cooper RG, Freemont AJ. TNF-alpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last? Rheumatology (Oxf) 2004;43:119-21.
13. Aoki Y, Rydevik B, Kikuchi S, et al. Local application of disc-related cytokines on spinal nerve roots. Spine 2002;27:1614-7.
14. Onda A, Yabuki S, Kikuchi S. Effects of neutralizing antibodies to tumor necrosis factor-alpha on nucleus pulposus-induced abnormal nociresponses in rat dorsal horn neurons. Spine 2003;28:967-72.
15. Petrovic P, Kalso E, Petersson KM, et al. Placebo and opioid analgesia: imaging a shared neuronal network. Science 2002;295:1737-40.